STRS Ohio’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,900
Closed -$75K 2195
2025
Q3
$75K Buy
+2,900
New +$67.2K ﹤0.01% 1916
2024
Q3
Sell
-6,600
Closed -$244K 1986
2024
Q2
$244K Buy
6,600
+700
+12% +$26.4K ﹤0.01% 1507
2024
Q1
$247K Buy
5,900
+3,200
+119% +$131K ﹤0.01% 1497
2023
Q4
$107K Buy
2,700
+1,300
+93% +$38.2K ﹤0.01% 1686
2023
Q3
$38K Sell
1,400
-5,100
-78% -$160K ﹤0.01% 1823
2023
Q2
$220K Buy
6,500
+500
+8% +$16.9K ﹤0.01% 1571
2023
Q1
$215K Buy
6,000
+4,800
+400% +$207K ﹤0.01% 1582
2022
Q4
$53K Buy
+1,200
New +$42.8K ﹤0.01% 1801
2022
Q1
Sell
-6,300
Closed -$243K 2154
2021
Q4
$243K Hold
6,300
﹤0.01% 1678
2021
Q3
$340K Buy
+6,300
New +$296K ﹤0.01% 1627
2015
Q3
Sell
-553
Closed -$157K 1890
2015
Q2
$209K Sell
553
-174
-24% -$69.1K ﹤0.01% 1551
2015
Q1
$303K Buy
+727
New +$260K ﹤0.01% 1355
2014
Q2
Sell
-1,013
Closed -$269K 1702
2014
Q1
$269K Hold
1,013
﹤0.01% 1355
2013
Q4
$368K Sell
1,013
-114
-10% -$43.9K ﹤0.01% 1282
2013
Q3
$599K Buy
1,127
+680
+152% +$233K ﹤0.01% 1148
2013
Q2
$105K Buy
+447
New +$88K ﹤0.01% 1623

Other funds holding CLDX